Tissue fibrosis that complicates chronic inflammation can be a cause of serious morbidity. The molecular links between inflammation and fibrosis appear to be a variety of proteins produced by activated chronic inflammatory cells. Collectively, these fibrogenic cytokines promote the growth of fibroblasts and the production of extracellular matrix that are the characteristic features of fibrotic tissue. In an attempt to clone cDNA for a fibrogenic lymphokine that we had isolated, we transfected COS-7 cells with a cDNA library derived from concanavalin A-stimulated lymphocyte line CDC25. Conditioned medium from the transfected COS-7 cells but not from sham-transfected cells stimulates fibroblast proliferation in vitro. We used heterologous expression in COS-7 cells of pools of CDC25 cDNA and screening for biological activity in conditioned medium to enrich for the cDNA clone(s) that encodes this activity. With this strategy of sib selection we isolated clone 2B3. The culture supernatants of 2B3-transfected COS-7 cells exert maximum growthstimulating effects on fibroblasts at a dilution of 1:20,000. The isolated cDNA has one open reading frame (216 nucleotides) that has no significant homology with nucleotide sequences that encode other proteins. A synthetic peptide constructed from the deduced amino acid sequence is biologically active in picomolar concentrations, even though it may represent only a portion of the native fibrosin. This lymphokine, which we designate fibrosin, may play a role in regulating fibrogenesis in certain chronic inflammatory diseases.
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Tissue fibrosis (scarring) develops as a complication of a variety of diseases with diverse etiologies and can result in serious, sometimes life-threatening, morbidity (1) . The realization that the scarring process (fibrogenesis) involves dynamic biological processes that include recruitment and proliferation of selected mesenchymal cells, such as fibroblasts, as well as increased net deposition of extracellular matrix constituents (most notably, collagen and glycosaminoglycans), has motivated a search for molecules that regulate these processes (2) (3) (4) . Particular interest has focused on soluble fibrogenic mediators produced by mononuclear phagocytes (monocytes and macrophages) (4) (5) (6) , and to a lesser extent also lymphocytes (7, 8) , since such chronic inflammatory cells may infiltrate anatomic sites prior to scar formation in certain diseases.
We have studied the molecular links between chronic inflammation and fibrosis in a murine model of schistosomiasis. In this helminthic infection, Schistosoma mansoni eggs are deposited in the liver, where egg-derived antigens drive specific T-lymphocyte responses that lead to the periovular recruitment of chronic inflammatory cells and the formation of egg granulomas. Fibrosis around the granulomas-and in some patients, massive liver fibrosis-ensues. The granuloma inflammatory cells produce a variety of proteins with fibrogenic activities promoting chemotaxis (9), mitogenesis (10), and excessive extracellular matrix synthesis (11) in fibroblasts, suggesting that these are mediators of hepatic fibrosis in this infection.
We purified the fibroblast mitogen produced by the egg granulomas, designated fibroblast-stimulating factor 1 (FsF-1), and determined that it is a product of activated CD4+ lymphocytes within the granulomas (12, 13) . This lymphokine has certain characteristics that distinguish it from other known fibroblast mitogens and other lymphokines (ref. 13 and unpublished data). Our efforts to date to obtain amino acid sequence data have been frustrated because FsF-1 is blocked to Edman degradation and is also strikingly resistant to enzymatic proteolysis. Accordingly, as an alternative approach to establish its molecular identity, we sought to clone FsF-1 by heterologous expression of a CD4+ lymphocyte-derived cDNA library in COS-7 cells. We now report that we have cloned and determined the sequence of a lymphocyte-derived cDNA that encodes fibrosin, a protein with potent fibroblast mitogenic activity. Its precise relationship to natural FsF-1 remains to be determined. § MATERIALS AND METHODS Fibroblast Proliferation Assay. Human diploid fibroblast cultures were established from newborn foreskins (14) . Cells were grown in either RPMI 1640 or Iscove's modified Dulbecco's medium (GIBCO) supplemented with antibiotics (penicillin, 100 units/ml; streptomycin, 100 ,ug/ml) and 10% heat-inactivated fetal bovine serum (FBS; GIBCO). Cells were grown to confluence in 75-cm2 tissue culture flasks (Costar) and passaged with 0.2% trypsin/0.1% EDTA (GIBCO). For the proliferation assay, 5-6 x i04 cells suspended in 1 ml of supplemented medium were. seeded per well in 24- (16) and has been used previously in cloning of murine lymphokine cDNAs (17, 18) .
Escherichia coli transformants containing the pcDSRa296 vectors were expanded in Luria-Bertani (LB) broth containing ampicillin (50 ,tg/ml), and plasmids were isolated on Qiagen columns (Qiagen, Chatsworth, CA). For transfection, 5 x 105 COS-7 cells (19) were seeded on 60-mm tissue culture dishes (Falcon) in supplemented Dulbecco's modified Eagle's medium (DMEM; GIBCO) containing 10% FBS (GIBCO). Cells were grown overnight to a density visually estimated to be 60-70% confluent. Cells were then washed with serum-free DMEM buffered with 50 mM Tris (pH 7.4), and plasmid DNA (1-5 ,tg) in serum-free medium (4 ml per plate) was added, followed by DEAE-dextran (200 Ag/ml; Pharmacia). After coincubation with plasmid DNA for 4-5 hr, COS-7 cells were washed and treated for 2-3 hr with 100 ,tM chloroquine (Sigma) in the presence of 2% FBS. Cells were then washed and grown overnight in DMEM with 4% FBS. The following day, cells were washed and replenished with DMEM containing BSA (0.3 mg/ml). Forty-eight to seventy-two hours later, culture supernatants were collected and tested for their ability to stimulate fibroblast proliferation.
For controls, COS-7 cells were transfected with the pcDSRa296 plasmid containing a murine interleukin 4 (IL-4) cDNA insert (DNAX) and were subsequently maintained under the above conditions, with minor modifications. Supernatants of these cultures were harvested after 72 hr and tested for IL-4 activity on an indicator cell line [HT-2 (20) ] and in the fibroblast proliferation assay.
DNA Nucleotide Sequence Analysis. Nucleotide sequences on both positive and negative cDNA strands were determined by the dideoxy chain-termination protocol with supercoiled DNA templates (21) . Conditions were modified as needed to sequence G + C-rich areas with compressions. The nucleotide sequence was compared with sequences in GenBank.
Peptide Synthesis. A 71-aa oligopeptide (Mr 7620, as confirmed by mass spectrometry) with sequence corresponding to that of the cDNA (Arg26-Leu96; see Fig. 5 ) was synthesized by the methods of tert-butyloxycarbonyl/N-methylpyrrolidone chemistry using a Perkin-Elmer Applied Biosystems model 430A peptide synthesizer (22) . The peptide was purified by HPLC on a Vydac C4 column and eluted in a single fraction with a trifluoroacetic acid/acetonitrile gradient.
RESULTS
CDC25 Lymphocyte Line Produces Fibroblast Mitogen. Of the 30 lymphocyte lines and T-T hybridomas we tested, 5 elaborated detectable fibroblast mitogenic activity into culture supernatants following their in vitro stimulation with Con A for 24 hr. Con A had no intrinsic fibroblast mitogenic activity in our fibroblast assay. We chose line CDC25 for further analysis. Culture supematants of CDC25 cells stimulated fibroblast
[3H]thymidine incorporation in a concentration-dependent manner; peak responses were detected at a concentration of 10% (the maximum tested; Fig. 1A ). Anti-FsF-1 IgG reduced the activity of the CDC25 culture supernatant by 47% at a concentration of 2.5 ,g/100 Al (Fig. 1B) (Fig. 2) . Because culture supernatants from IL-4 cDNA transfectants, which contained IL-4 at 200-250 units/ml as judged from results in the HT-2 proliferation assay, had minimal effects on fibroblast proliferation, we concluded that the CDC25 library contained cDNA that specifically encoded a fibroblast mitogen that was not IL-4. We used sib selection as a strategy to clone this cDNA.
The CDC25 library was partitioned into pools of 103 clones that were seeded into separate wells of microtiter plates containing LB broth and ampicillin. Pools estimated to contain 104 clones were prepared by combining wells within a row. COS-7 cells were transfected with plasmid DNA prepared from these pools and the transfectant culture supernatants tested at various concentrations, to a maximum of 10%, were assayed for their ability to enhance fibroblast [3H]thymidine uptake at least 2-to 3-fold above background at any concentration tested (positive transfectant).
Of the 20 pools initially prepared and tested, 3 (15%) were positive. One of the three pools (pool B) was selected because the biological activity in the supernatant of pool B transfectants could be neutralized with anti-FsF-1 IgG. Pool B was subdivided into 8 separate pools (each containing 103 clones), and plasmid DNA prepared from each pool was used to transfect COS-7 cells. Conditioned medium from four of the transfectants (50%) had significant mitogenic activity. Based on antibody neutralization of bioactivity, 1 of the pools (2B) was selected. Pool 2B was then subdivided into 16 pools, each estimated to contain 100 clones. Five of the pools (31%) produced positive transfectants. Two of the positive pools were plated on solid agar, and 10 colonies were screened; 8 of these colonies produced positive transfectants.
One of the clones (2B3) was subcloned twice on solid agar and analyzed in detail. Supernatant of 2B3 transfectant was active in a fibroblast growth assay over a wide concentration range; the log-linear dose-response relationship was biphasic (Fig. 3A) . Anti-FsF-1 IgG virtually abolished the fibrogenic activity of 2B3 transfectant supernatant (Fig. 3B) . With each round of sib selection, the potency of transfectant culture supernatant increased 2000-fold from transfection with the whole library to transfection with 2B3 clone (Fig. 4) (Fig. 6) . Notably, in 12 separate assays (6 in which cells were assayed after 72 hr of incubation and 6 after 96 hr of incubation), peak mitogenic activity was observed with peptide concentrations between 0.1 and 10 pM; a second peak of activity was detected at concentrations in the 1 ,uM range.
DISCUSSION
We previously identified FsF-1 as a fibroblast growthstimulating lymphokine produced by CD4+ lymphocytes (13) . Using biological activity and its neutralization with anti-FsF-1 IgG antibody, we screened culture supernatants of established murine T-lymphocyte lines that had been stimulated with Con A. We identified a CD4+ lymphocyte line CDC25 as one apparently able to produce FsF-1 (Fig. 1) , and screened a CDC25 cDNA library by heterologous expression in COS-7 cells. The very high level of expression afforded by the design of the pcDSRa296 promoter elements permitted us to detect fibroblast mitogenic activity in conditioned medium from COS-7 cells transfected with the entire library (Fig. 2) . Sib selection resulted in progressively enhanced potency of the fibroblast mitogenic activity in transfectant culture supernatants (Fig. 4) and ultimately resulted in the isolation of clone 2B3. 2B3cDNA encodes a protein with fibroblast mitogenic activity that is neutralized or adsorbed with anti-FsF-1 antibody (Fig. 3) .
Analysis (24) . If it does serve this function, cleavage would be expected at the alanine residue at position 15 or 20 of the fusion protein, resulting in a mature peptide containing 81 or 76 aa (predicted mass, 9-10 kDa). Alternative cleavage sites might exist. Since gel filtration chromatography of the transfectant culture supernatants gave fibroblast mitogenic activity in fractions corresponding to a molecular mass of 30 kDa (S.P., unpublished data), the protein may be further modified in vivo by glycosylation.
The 71-aa synthetic 2B3 peptide which was made from the deduced amino acid sequence of the clone was biologically active (Fig. 6) , thus confirming the deduced sequence. The dose-response pattern we observed with the synthetic peptide is reminiscent of our experience with crude and purified natural FsF-1 (12, 14) as well as with supernatants of the 2B3 transfectant (Fig. 3) . We have not had sufficient material to ascertain whether, like the 2B3 peptide, natural FsF-1 gives rise to a second peak of growth stimulation at higher concentrations. Although we currently have no explanation for the dose-response pattern, the possibility exists that it reflects multiple receptors with differing ligand affinities.
The 2B3 cDNA possesses no significant homology with other archived nucleotide sequences, and we have designated the corresponding protein fibrosin. The crossreactivity of polyclonal anti-FsF-1 antibody with fibrosin (Fig. 3B) suggests that the two lymphokines may be similar or identical.
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Fibrosin differs in biological activity from IL-4 and transforming growth factor ,3, two known lymphokines with fibrogenic activity. Whereas transforming growth factor ,B and IL-4 are potent fibroblast chemoattractants (25, 26) and stimulate enhanced extracellular matrix synthesis (27, 28) , they appear to have little direct mitogenic effect on fibroblasts in the absence of other growth factors (27, 29) . In contrast, fibrosin is at least as potent as acidic and basic fibroblast growth factor when tested in our standard fibroblast proliferation assay (12) . It can also be anticipated that fibrosin, like the other fibrogenic lymphokines, will prove to be multifunctional and may exert biological effects in addition to ones involved in fibrosis.
